The FDA has recently issued an alert on the potential dangers of the controversial CCSVI Multiple Sclerosis treatment. It is also sometimes known as “liberation therapy” or a “liberation procedure.” Some researchers theorize that Multiple Sclerosis is caused by the gradual narrowing of blood vessels, which inhibits drainage of blood from the brain and spinal cord. Called cerebrospinal venous insufficiency, or CCSVI, this disorder has not been conclusively linked to Multiple Sclerosis, and yet some doctors are performing controversial and dangerous surgeries to widen blood vessels using stents and balloons. The FDA is now warning that these medical devices are not approved for CCSVI, and people who have undergone this treatment have suffered strokes, permanent disability, and death.
What You Can Do & How a CCSVI Lawsuit Can Help
The Schmidt Firm, PLLC is currently accepting CCSVI Multiple Sclerosis Treatment induced injury cases in all 50 states. If you or somebody you know has been injured by CCSVI treatment, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our CCSVI Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
CCSVI Multiple Sclerosis Treatment
Multiple Sclerosis (MS) is a progressive, degenerative disease that affects the brain and spinal-cord. The lining around the nerve fibers in the brain (called the myelin) and often the nerve fibers themselves are progressively damaged. This causes severe physical and neurological symptoms.
There is no known cause of Multiple Sclerosis, but in 2009, one researcher proposed that the disease was caused by chronic cerebrospinal venous insufficiency (CCSVI), which is a narrowing of the veins in the neck and chest. The researchers proposed that CCSVI prevents adequate blood drainage from the brain and spinal cord. CCSVI treatment typically involves using special balloons or stents to widen the blood vessels in the chest and neck.
The link between CCSVI and MS is inconclusive. CCSVI treatment is experimental, and there have been no scientific studies or controlled clinical trials regarding the safety or effectiveness of using balloons or stents to treat CCSVI.
CCSVI Treatment Side Effects
The FDA has received reports of the following CCSVI Multiple Sclerosis treatment injuries:
- Migration of the stent inside a blood vessel
- Damage to the treated veins
- Blood clots, which can cause stroke, heart attack, etc.
- Cranial nerve damage
- Abdominal bleeding
The FDA warns: “Balloon angioplasty devices and stents have not been approved by the FDA for use in treating CCSVI.”
Do I have a CCSVI Multiple Sclerosis Treatment Lawsuit?
The Schmidt Firm, PLLC is currently accepting CCSVI treatment injury cases in all 50 states. If you or somebody you know has been injured by CCSVI multiple sclerosis treatment, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our CCSVI Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.